EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts

Matthew L Edin, Artiom Gruzdev, J Alyce Bradbury, Joan P Graves, Fred B Lih, Laura M DeGraff, Ingrid Fleming, Darryl C Zeldin

Journal of Biological Chemistry · 2023-04 · 299 (4) · 103049

DOI: 10.1016/j.jbc.2023.103049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-04. Verfasst von Matthew L Edin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Intramural Research, National Institute for Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North C…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Myocardium. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Deutsche Forschungsgemeinschaft, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochromes P450 metabolize arachidonic acid to epoxyeicosatrienoic acids (EETs) which have numerous effects. After cardiac ischemia, EET-induced coronary vasodilation increases delivery of oxygen/nutrients to the myocardium, and EET-induced signaling protects cardiomyocytes against postischemic mitochondrial damage. Soluble epoxide hydrolase 2 (EPHX2) diminishes the benefits of EETs through hydrolysis to less active dihydroxyeicosatrienoic acids. EPHX2 inhibition or genetic disruption improves recovery of cardiac function after ischemia. Immunohistochemical staining revealed EPHX2 expression in cardiomyocytes and some endothelial cells but little expression in cardiac smooth muscle cells or fibroblasts. To determine specific roles of EPHX2 in cardiac cell types, we generated mice with cell-specific disruption of Ephx2 in endothelial cells (Ephx2fx/fx/Tek-cre) or cardiomyocytes (Ephx2fx/fx/Myh6-cre) to compare to global Ephx2-deficient mice (global Ephx2-/-) and WT (Ephx2fx/fx) mice in expression, EET hydrolase activity, and heart function studies. Most cardiac EPHX2 expression and activity is in cardiomyocytes with substantially less activity in endothelial cells. Ephx2fx/fx/Tek-cre hearts have similar EPHX2 expression, hydrolase activity, and postischemic cardiac function as control Ephx2fx/fx hearts. However, Ephx2fx/fx/Myh6-cre hearts were similar to global Ephx2-/- hearts with significantly diminished EPHX2 expression, decreased hydrolase activity, and enhanced postischemic cardiac function compared to Ephx2fx/fx hearts. During reperfusion, Ephx2fx/fx/Myh6-cre hearts displayed increased ERK activation compared to Ephx2fx/fx hearts, which could be reversed by EEZE treatment. EPHX2 did not regulate coronary vasodilation in this model. We conclude that EPHX2 is primarily expressed in cardiomyocytes where it regulates EET hydrolysis and postischemic cardiac function, whereas endothelial EPHX2 does not play a significant role in these processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacMyocardiumMiceAnimalsIschemiaEicosanoidsReperfusionHydrolasesEpoxide Hydrolases

Stichwörter der Autor:innen

EETsEPHX2Langendorffepoxide hydrolaseheart

Substanzen

EicosanoidsHydrolasesEpoxide HydrolasesEphx2 protein, mouse

Autor:innen und Institutionen

  • Division of Intramural Research, National Institute for Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
  • Institute for Vascular Signaling, Centre of Molecular Medicine, Goethe University, Frankfurt am Main, Germany.
  • Division of Intramural Research, National Institute for Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA. Electronic address: zeldin@niehs.nih.gov.

Förderung

  • Intramural NIH HHS
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
  • National Institute of Environmental Health Sciences
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Edin, M. L., Gruzdev, A., Bradbury, J. A., Graves, J. P., Lih, F. B., DeGraff, L. M., Fleming, I., & Zeldin, D. C. (2023). Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts. Journal of Biological Chemistry, 299(4), 103049. https://doi.org/10.1016/j.jbc.2023.103049

Vancouver

Edin ML, Gruzdev A, Bradbury JA, Graves JP, Lih FB, DeGraff LM, et al. Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts. Journal of Biological Chemistry. 2023;299(4):103049. doi:10.1016/j.jbc.2023.103049

BibTeX
@article{Edin2023,
  author = {Edin, Matthew L and Gruzdev, Artiom and Bradbury, J Alyce and Graves, Joan P and Lih, Fred B and DeGraff, Laura M and Fleming, Ingrid and Zeldin, Darryl C},
  title = {Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  volume = {299},
  number = {4},
  pages = {103049},
  doi = {10.1016/j.jbc.2023.103049}
}
Kostenlos starten →